journal article·2020-11

The peculiar dissolution behaviour of Piretanide hosted in layered double hydroxides

Marianna Guagliano, Francesco Monteforte, Giovanna Bruni, Valeria Friuli, Lauretta Maggi, Irene Quinzeni, Marcella Bini

Publisher page

Abstract

Abstract Layered double hydroxides (LDHs) are widely used as inorganic hosts for different applications, in particular for drug delivery. Piretanide, a poorly soluble diuretic drug, could benefit of the association with LDH for improving the dissolution rate and also for limiting the gastric irritation after its repeated administration thanks to natural antacid properties of LDH. In this paper, the hybrids compounds Piretanide-Mg3Al-LDH and Zn3Al-LDH were synthesized by co-precipitation method. The first proofs to demonstrate the successful intercalation came from X-ray powder diffraction (from hydroxide layers expansion with respect to LDH-carbonate), thermal analysis (from the absence of drug melting point in the hybrid compound) and infrared spectroscopy (from the absence of the carboxylic acid vibration in the hybrid). In addition, SEM microscopy/EDS microanalysis supported the formation of new entities. Both compounds showed a significant improvement of the drug dissolution rate, compared to the active alone, in biorelevant conditions simulating the oral administration.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Layered Double Hydroxides Synthesis and Applications · Magnesium Oxide Properties and Applications · Mesoporous Materials and Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (32)

Show source-provided references
1. Intercalation behaviour of L-ascorbic acid into layered double hydroxides10.1016/j.clay.2006.09.003 ↗
2. Hybrid nanocomposites of layered double hydroxides: an update of their biological applications and future prospects, Colloid Polym
3. Effect of hydrotalcite-like compounds on the aqueous solubility of some poorly water-soluble drugs10.1002/jps.10411 ↗
4. Effect of gliclazide immobilization into layered double hydroxide on drug release10.1016/j.ejpb.2009.06.007 ↗
5. Layered double hydroxides (LDHs): versatile and powerful hosts for different applications10.15406/japlr.2018.07.00206 ↗
6. Hybrid compounds for improving drugs solubility: synthesis, physicochemical and pharmaceutical characterization of Nimesulide-LDH10.1016/j.jssc.2019.02.001 ↗
7. Improving the carprofen solubility: synthesis of the Zn2Al-LDH hybrid compound10.1016/j.xphs.2017.09.019 ↗
8. Preparation of piretanide polymorphs and their physicochemical properties and dissolution behaviours10.1248/cpb.42.1123 ↗
9. Preparation of amorphous and polymorph piretanide and their physicochemical properties and solubilities10.1248/cpb.44.1614 ↗
10. Structural characterization and thermal and chemical stability of bioactive molecule–hydrotalcite (LDH) nanocomposites10.1039/c3cp51235e ↗
11. Hydrotalcite-like compounds: Versatile layered hosts of molecular anions with biological activity10.1016/j.micromeso.2007.02.005 ↗
12. Mg, Al layered double hydroxides with intercalated indomethacin: synthesis, characterization, and pharmacological study10.1002/jps.20054 ↗
13. Synthesis of isopolymetalate-pillared hydrotalcite via organic anion-pillared precursors10.1021/ic00298a024 ↗
14. A study of structural memory effects in synthetic hydrotalcites using environmental SEM10.1016/j.matlet.2004.08.035 ↗
15. Piretanide: a loop-active diuretic. Pharmacology, therapeutic efficacy and adverse effects10.1002/j.1875-9114.1984.tb03348.x ↗
16. Recent advancements in two-dimensional nanomaterials for drug delivery
17. Layered double hydroxides: a brief review from fundamentals to application as evolving biomaterials10.1016/j.clay.2017.12.021 ↗
18. Meloxicam-LDH hybrid compound: a successful strategy to improve solubility
19. A novel organic–inorganic microhybrids containing anticancer agent doxifluridine and layered double hydroxides: structure and controlled release properties10.1016/j.ces.2010.03.013 ↗
20. Dissolution kinetics and mechanism of Mg–Al layered double hydroxides: a simple approach to describe drug release in acid media10.1016/j.jcis.2010.07.053 ↗
21. Pectin-coated chitosan–LDH bionanocomposite beads as potentialsystems for colon-targeted drug delivery10.1016/j.ijpharm.2013.12.035 ↗
22. Intercalation of drugs in layered double hydroxides and their controlled release: a review10.1016/j.clay.2013.12.002 ↗
23. Modeling drug release from a layered double hydroxide–ibuprofen complex10.1016/j.clay.2012.04.004 ↗
24. Structural and physicochemical aspects of drug release from layered double hydroxides and layered hydroxide salts10.1016/j.clay.2015.02.030 ↗
25. Layered double hydroxide as novel antibacterial drug delivery system10.1016/j.jpcs.2009.12.066 ↗
26. Characterisation of Diclofenac, Ketoprofen or Chloramphenicol succinate encapsulated in layered double hydroxides with the hydrotalcite-type structure10.1016/j.clay.2011.11.010 ↗
27. Nickel-iron layered double hydroxide nanostructures for micro solid phase extraction of nonsteroidal anti-inflammatory drugs, followed by quantitation by HPLC-UV10.1007/s00604-019-3419-4 ↗
28. Multifunctional substances -Determination of pKa-values by various methods10.1007/BF00321579 ↗
29. Mechanism of hydrotalcite regeneration10.1023/A:1010914900966 ↗
30. USP40 · 2017 · 2409
31. Strategies to address low drug solubility in discovery and development10.1124/pr.112.005660 ↗
32. Layered double hydroxide nanostructures and nanocomposites for biomedical applications10.1039/C9TB01312A ↗